JP2017524036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524036A5 JP2017524036A5 JP2017527546A JP2017527546A JP2017524036A5 JP 2017524036 A5 JP2017524036 A5 JP 2017524036A5 JP 2017527546 A JP2017527546 A JP 2017527546A JP 2017527546 A JP2017527546 A JP 2017527546A JP 2017524036 A5 JP2017524036 A5 JP 2017524036A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- general formula
- linear
- free fatty
- carbon chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 9
- 235000021588 free fatty acids Nutrition 0.000 claims 9
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 125000005647 linker group Chemical group 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000005496 eutectics Effects 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 229920000765 poly(2-oxazolines) Polymers 0.000 claims 1
- 229920001584 poly(acrylomorpholines) Polymers 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 230000003381 solubilizing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462035393P | 2014-08-09 | 2014-08-09 | |
| US62/035,393 | 2014-08-09 | ||
| PCT/US2015/044501 WO2016025401A1 (en) | 2014-08-09 | 2015-08-10 | Oral composition for delivery of drugs and other substances |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524036A JP2017524036A (ja) | 2017-08-24 |
| JP2017524036A5 true JP2017524036A5 (cg-RX-API-DMAC7.html) | 2018-09-20 |
| JP6759203B2 JP6759203B2 (ja) | 2020-09-23 |
Family
ID=55304531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527546A Active JP6759203B2 (ja) | 2014-08-09 | 2015-08-10 | 薬物及び他の物質の送達のための経口組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9872908B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3177279B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6759203B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102507657B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107072967B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015301952B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2956960C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3177279T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3033965T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL250394B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016025401A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6759203B2 (ja) * | 2014-08-09 | 2020-09-23 | アバンティ・ポーラ・リピッド・インコーポレイテッド | 薬物及び他の物質の送達のための経口組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2514755A1 (fr) | 1981-10-21 | 1983-04-22 | Rhone Poulenc Chim Base | Procede de preparation de l'anhydride acetique |
| JPS58152812A (ja) * | 1982-02-17 | 1983-09-10 | チバ−ガイギ−・アクチエンゲゼルシヤフト | 水性相中単層脂質顆粒の製造方法 |
| EP0088046B1 (de) * | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| IE59067B1 (en) * | 1985-04-02 | 1993-12-15 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| JPH01274830A (ja) * | 1988-04-28 | 1989-11-02 | Asahi Denka Kogyo Kk | 安全で且つ高度な界面活性を有する脂質組成物 |
| JPH03127731A (ja) * | 1989-10-12 | 1991-05-30 | Yakult Honsha Co Ltd | ビタミンｅの可溶化方法およびビタミンｅ製剤 |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| CA2662607A1 (en) * | 2006-09-08 | 2008-03-13 | Kaneka Corporation | Composition comprising reduced coenzyme q10 and lysolecithin |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| JP6759203B2 (ja) * | 2014-08-09 | 2020-09-23 | アバンティ・ポーラ・リピッド・インコーポレイテッド | 薬物及び他の物質の送達のための経口組成物 |
-
2015
- 2015-08-10 JP JP2017527546A patent/JP6759203B2/ja active Active
- 2015-08-10 WO PCT/US2015/044501 patent/WO2016025401A1/en not_active Ceased
- 2015-08-10 CN CN201580049486.0A patent/CN107072967B/zh active Active
- 2015-08-10 DK DK15832041.6T patent/DK3177279T3/da active
- 2015-08-10 KR KR1020227016492A patent/KR102507657B1/ko active Active
- 2015-08-10 ES ES15832041T patent/ES3033965T3/es active Active
- 2015-08-10 US US14/822,289 patent/US9872908B2/en active Active
- 2015-08-10 CA CA2956960A patent/CA2956960C/en active Active
- 2015-08-10 EP EP15832041.6A patent/EP3177279B1/en active Active
- 2015-08-10 AU AU2015301952A patent/AU2015301952B2/en active Active
- 2015-08-10 KR KR1020177006233A patent/KR20170033442A/ko not_active Ceased
-
2017
- 2017-02-01 IL IL250394A patent/IL250394B/en active IP Right Grant
- 2017-11-08 US US15/807,389 patent/US10463738B2/en active Active
-
2019
- 2019-10-31 US US16/669,825 patent/US11510985B2/en active Active